China is posing risks to global economic growth as Premier Li Keqiang's three-month-old government is squeezing credit.
The People's Bank of China, which controls the world's second-largest economy's banking system, recently refused to inject more cash into the financial system, even as short-term borrowing costs are on the rise.
GDP growth rate fell to 7.8 per cent last year; and most economists fear that the government will not be able to meet its target 7.5 per cent growth this year.
Shane Oliver, head of AMP Capital Investors Ltd's investment strategy, said, "I wasn't too worried up until this week. Things are quite a lot different in China than might have been expected. It does potentially pose risks for global growth."
Oliver is one of the many economists who have lowered their outlook for the Chinese economy.
China has so far been playing a vital role in the global economic recovery. Last year, the Chinese economy accounted for nearly a third of global growth. Countries from Brazil to Australia are increasingly relying on Chinese economy as developed economies are still struggling to recover from the worst global recession since World War II.
Thus, any fall in Chinese economy would also hurt the global economic growth.
There are a lot of things not going right at the IRS and mostly so when it comes to filing for Earned Income Tax Credits (EITC).
In December 2014, a report by Watchdog.org showed that that an audit by the IRS documented twenty four percent...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
There was a time just a few years back when Spain ranked second after Greece, as a figure of the euro zone's huge debt crisis and economic slowdown. The country's unemployment climbed to a huge twenty seven percent and the economy was still...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
On Tuesday, tech giant Google released latest to show how much of its online traffic is...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
On Thursday, the US Federal Bureau of Investigation (FBI...
In an announcement made via a blog post on Thursday,...
In a blog post published on Wednesday, Twitter-owned...
A draft New York legislation proposes the use of a...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).